Infectious Disease · Pittsburgh, PA
NPI
1407821143
Since 2006
Specialty
Infectious Disease
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3601 5th Ave, Pact - Falk, Suite 700
Pittsburgh, PA, 15213
Phone (412) 647-7228
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,592
81 services
Medicare patients, 2024
23
Average age 68
Drug cost, 2024
$4.1M
4,289 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deborah McMahon was code 99214 (office e&m - established), 31 times for 19 patients. In total Deborah McMahon billed 81 services in 6 codes, and Medicare paid $3,592.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 31 | 19 | $60.82 | $1,885 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 30 | 21 | $10.82 | $325 |
By year: 2022 $1,960 for 46 services; 2023 $1,867 for 41 services; 2024 $3,592 for 81 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deborah McMahon prescribed most often to Medicare patients was Atorvastatin Calcium, with 246 prescriptions and refills. In total Deborah McMahon wrote 4,289 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 246 | 396 | 47 | $1,882 |
| Descovy Emtricitabine/Tenofov Alafenam | 188 | 188 | 19 | $398K |
| Tivicay Dolutegravir Sodium | 176 | 176 | 20 | $451K |
| Lisinopril Generic | 158 | 262 | 30 | $949 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 152 | 152 | 25 | $574K |
| Juluca Dolutegravir/Rilpivirine | 137 | 137 | 15 | $457K |
| Pifeltro Doravirine | 134 | 140 | 15 | $236K |
| Gabapentin Generic | 131 | 137 | 18 | $1,663 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 115 | 115 | 12 | $398K |
| Rosuvastatin Calcium Generic | 111 | 165 | 18 | $1,010 |
| Dovato Dolutegravir Sodium/Lamivudine | 110 | 110 | 13 | $320K |
| Amlodipine Besylate Generic | 100 | 140 | 15 | $497 |
| Trulicity Dulaglutide | 90 | 94 | 11 | $86K |
| Losartan Potassium Generic | 86 | 110 | 16 | $506 |
| Duloxetine Hcl Generic | 75 | 85 | Under 11 | $629 |
Brand drugs: 1,597 claims; generic drugs: 2,668 claims; opioid claims: 69.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Deborah McMahon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.